| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.00082 | 1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |